ISCRAM · Registering as Listener

International Symposium on Cardiovascular Risk Assessment and Management

18th Dec – 19th Dec 2026 Milan, Italy Standard / Physical Participation
Listener Registration From
$—
$— in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

For Support Please Contact

Coupon code

Have a code? Apply it here — the discount updates the total immediately.

Apply
VISA MC AMEX UPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceISCRAM
ModeStandard / Physical
ParticipationListener
Registration fee$—
Bank charges (5.8%)$—
Discount-$0.00
Total payable $—

Includes all bank processing charges — the amount above is exactly what will be charged. View charge breakdown

Need help?

Contact our registration team:

Benefits of Registering as Listener
Access to Conference Sessions
Networking Opportunities
Certificate of Participation
Invitation Letter Support
Conference Kit / Materials
Access to Keynote Sessions
Conference Session Tracks
SDG Wheel

SDG-Aligned Research Themes

International Symposium on Cardiovascular Risk Assessment and Management conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 - Good Health and Well-being SDG 4 - Quality Education SDG 9 - Industry, Innovation and Infrastructure SDG 10 - Reduced Inequalities

This track focuses on the latest advancements in tools and methodologies for assessing cardiovascular risk. Emphasis will be placed on integrating technology and data analytics into traditional risk assessment frameworks.

This session will explore effective preventive measures aimed at reducing the incidence of heart disease. Discussions will include lifestyle modifications, pharmacological interventions, and community health initiatives.

This track will delve into the various risk stratification models used in clinical cardiology. Participants will examine the effectiveness of these models in guiding treatment decisions and improving patient outcomes.

This session will highlight the role of public health initiatives in combating cardiovascular diseases. Topics will include population-based strategies, policy implications, and the impact of socioeconomic factors on heart health.

This track will discuss new trends and research findings in the prevention of heart disease. Focus will be placed on innovative approaches and their potential for implementation in diverse populations.

This session will review the latest clinical guidelines for managing cardiovascular risk. Experts will discuss the implications of these guidelines for practitioners and their role in improving patient care.

This track will examine the interplay between cardiovascular disease and other comorbid conditions. Discussions will focus on integrated care approaches and the challenges of managing multiple health issues.

This session will explore cutting-edge imaging technologies that enhance cardiovascular risk assessment. Participants will learn about the role of imaging in diagnosis, treatment planning, and monitoring of heart disease.

This track will focus on the importance of patient engagement and shared decision-making in cardiovascular care. Strategies for improving communication and adherence to treatment plans will be discussed.

This session will provide insights into cardiovascular health challenges and strategies from a global perspective. Participants will explore how cultural, economic, and environmental factors influence cardiovascular risk.

This track will highlight emerging research areas and future directions in cardiovascular risk assessment and management. Discussions will include potential breakthroughs and their implications for clinical practice.

COPYRIGHT © 2026 International Symposium on Cardiovascular Risk Assessment and Management. ALL RIGHTS RESERVED